Institut Curie Support Service. How to file a complaint or leave a suggestion?
This online resource is not an official company website, is not affiliated with it by affiliation, partnership or representation and does not act on its behalf. Information is posted for informational purposes only. Current and legally significant information is published exclusively on the official company website: https://institut-curie.org
Phone: 33144324000
Email: [email protected]
Go to company website
Address and phone
| Contacts | |
| operator: | +33144324000 |
| operator: | +33156245500 |
| operator: | +33147111515 |
| operator: | +33169863000 |
| Donor relations: | [email protected] |
| International patient service: | [email protected] |
| Data Protection Officer: | [email protected] |
| Support the Institut Curie | |
| Country: | France |
| Social networks: | Linkedin, Twitter, Facebook, Openx, Instagram, Facebook, Linkedin, Threads, Youtube |
| Legal name: | Institut Curie https://institut-curie.org |
| Address: | 26 rue d'Ulm, Paris, 75248, France |
| Link to vacancies: | https://institut-curie.org/job-offers |
| Awards and certifications: |
|
| Company policies: | Personal data protection charter, Legal notice, Cookies management |
| Google Business Profile: | Google Maps |
| Media mentions: | nature.com, theguardian.com, lemonde.fr, bioworld.com, euronews.com |
Working time
| Not specified |
Feedback form

Fill out the form
Complaints and suggestions form

Write a complaint
About the company
| Description: | Institut Curie is a non-profit private foundation located in Paris and Saint-Cloud, France, established in 1909. The organization consists of a research center and a hospital group specialized in oncology, employing approximately 3,700 staff and 1,100 researchers. The facility provides care to more than 75,000 patients annually and operates 300 beds. |
| Categories: |
|
| Year of foundation: | 1909 |
| Founders: | Marie Curie;Claudius Regaud |
| News: | The institution signed a strategic partnership with the CEA and Thales to build a unique FLASH radiotherapy platform designed to accelerate cancer treatments globally. Researchers presented promising advances at the AACR Congress 2026, which included optimized CAR-T cells, vaccinotherapy, super-responders, and improved oncogenetic follow-up protocols. Another published study detailed findings regarding the unsuspected powers of intestinal epithelial cells on the microbiota during the early stages of life. Furthermore, the organization collaborated with Université PSL and INSERM to establish the specialized Institute of Women's Cancers. This newly created international structure focuses comprehensively on dedicated research and medical innovation to put women at the heart of care. |
How quickly did you manage to contact support?
Couldn't get through!
31
1-3 minutes
11
5-10 minutes
6

About ratings and reviews
Ratings are based on recent reviews from people in your region
Device type